MolPharm xPharm- The Comprehensive Pharmacology Reference

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Gopalakrishnan, M.
Right arrow Articles by Sullivan, J. P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Gopalakrishnan, M.
Right arrow Articles by Sullivan, J. P.

0026-895X/97/030524-11$3.00/0
Copyright © by The American Society for Pharmacology and Experimental Therapeutics
All rights of reproduction in any form reserved.
MOLECULAR PHARMACOLOGY 52:524-534 (1997).

Regulation of Human alpha 4beta 2 Neuronal Nicotinic Acetylcholine Receptors by Cholinergic Channel Ligands and Second Messenger Pathways

Murali Gopalakrishnan, Eduardo J. Molinari, and James P. Sullivan

Neuroscience Research, Pharmaceutical Products Division, Abbott Laboratories, Abbott Park, Illinois 60064-3500

The alpha 4beta 2 nicotinic acetylcholine receptors (nAChRs), a major subtype in the brain, have been shown to be modulated by chronic treatment with nicotine. In this study, the regulation of recombinant human alpha 4beta 2 nAChR subtype by (-)-nicotine and other cholinergic channel modulators was studied using human embryonic kidney 293 cells stably expressing this subunit combination. The treatment of transfected cells with (-)-nicotine and other activator ligands, including (-)-cytisine, 1,1-dimethyl-4-phenylpiperazinium, (S)-3-methyl-5-(1-methyl-2-pyrrolidinyl)isoxazole, and (±)-epibatidine, resulted in concentration-dependent increases in the levels of alpha 4beta 2 nAChRs. The increase in [3H]cytisine binding sites was initiated by low concentrations of (-)-nicotine (<100 nM); was maximal at 10 µM (15-fold), rapid (t0.5 = 4.0 ± 0.5 hr), and totally reversible (t0.5 = 11.7 ± 0.1 hr); and occurred with no change in ligand binding affinity. Antagonists, including dihydro-beta -erythroidine, d-tubocurarine, and methyllycaconitine, also elicited significant increases in receptor levels. A good correlation was observed between the Ki values for binding inhibition and the EC50 values for receptor up-regulation. Treatment of cells with mecamy-lamine, a noncompetitive antagonist, did not change receptor levels or alter (-)-nicotine-evoked up-regulation. (-)-Nicotine-evoked up-regulation was blocked by cycloheximide, suggesting a role for protein synthesis. Treatment of cells with (-)-nicotine or dihydro-beta -erythroidine differentially modulated the efficacy of acetylcholine to activate cation efflux. Both 6-beta -[beta '(piperidino)propionyl]forskolin and phorbol-12-myristate-13-acetate increased [3H]cytisine binding sites and nAChR function and enhanced the effects of chronic (-)-nicotine treatment in a synergistic manner. These results collectively demonstrate that human alpha 4beta 2 nAChRs can be differentially up-regulated by chronic treatment with nAChR ligands and activation of protein kinase A- and protein kinase C-dependent mechanisms.


Copyright © by The American Society for Pharmacology and Experimental Therapeutics



This article has been cited by other articles:


Home page
JNMHome page
A. G. Mukhin, A. S. Kimes, S. I. Chefer, J. A. Matochik, C. S. Contoreggi, A. G. Horti, D. B. Vaupel, O. Pavlova, and E. A. Stein
Greater Nicotinic Acetylcholine Receptor Density in Smokers Than in Nonsmokers: A PET Study with 2-18F-FA-85380
J. Nucl. Med., October 1, 2008; 49(10): 1628 - 1635.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
L. C. Gahring, A. V. Osborne-Hereford, G. A. Vasquez-Opazo, and S. W. Rogers
Tumor Necrosis Factor {alpha} Enhances Nicotinic Receptor Up-regulation via a p38MAPK-dependent Pathway
J. Biol. Chem., January 11, 2008; 283(2): 693 - 699.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
M. Kishi and J. H. Steinbach
Role of the Agonist Binding Site in Up-Regulation of Neuronal Nicotinic {alpha}4beta2 Receptors
Mol. Pharmacol., December 1, 2006; 70(6): 2037 - 2044.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
Y. Xiao, H. Fan, J. L. Musachio, Z.-L. Wei, S. K. Chellappan, A. P. Kozikowski, and K. J. Kellar
Sazetidine-A, A Novel Ligand That Desensitizes {alpha}4beta2 Nicotinic Acetylcholine Receptors without Activating Them
Mol. Pharmacol., October 1, 2006; 70(4): 1454 - 1460.
[Abstract] [Full Text] [PDF]


Home page
Pharmacol. Rev.Home page
M. Raiteri
Functional pharmacology in human brain.
Pharmacol. Rev., June 1, 2006; 58(2): 162 - 193.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
A. Kuryatov, J. Luo, J. Cooper, and J. Lindstrom
Nicotine Acts as a Pharmacological Chaperone to Up-Regulate Human {alpha}4{beta}2 Acetylcholine Receptors
Mol. Pharmacol., December 1, 2005; 68(6): 1839 - 1851.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
M. B. Ficklin, S. Zhao, and G. Feng
Ubiquilin-1 Regulates Nicotine-induced Up-regulation of Neuronal Nicotinic Acetylcholine Receptors
J. Biol. Chem., October 7, 2005; 280(40): 34088 - 34095.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
Y. F. Vallejo, B. Buisson, D. Bertrand, and W. N. Green
Chronic Nicotine Exposure Upregulates Nicotinic Receptors by a Novel Mechanism
J. Neurosci., June 8, 2005; 25(23): 5563 - 5572.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
T. Darsow, T. K. Booker, J. C. Pina-Crespo, and S. F. Heinemann
Exocytic Trafficking Is Required for Nicotine-induced Up-regulation of {alpha}4{beta}2 Nicotinic Acetylcholine Receptors
J. Biol. Chem., May 6, 2005; 280(18): 18311 - 18320.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
G. Y. Lopez-Hernandez, J. Sanchez-Padilla, A. Ortiz-Acevedo, J. Lizardi-Ortiz, J. Salas-Vincenty, L. V. Rojas, and J. A. Lasalde-Dominicci
Nicotine-induced Up-regulation and Desensitization of {alpha}4{beta}2 Neuronal Nicotinic Receptors Depend on Subunit Ratio
J. Biol. Chem., September 3, 2004; 279(36): 38007 - 38015.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
J. Sallette, S. Bohler, P. Benoit, M. Soudant, S. Pons, N. Le Novere, J.-P. Changeux, and P. J. Corringer
An Extracellular Protein Microdomain Controls Up-regulation of Neuronal Nicotinic Acetylcholine Receptors by Nicotine
J. Biol. Chem., April 30, 2004; 279(18): 18767 - 18775.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
J. B. Eaton, J.-H. Peng, K. M. Schroeder, A. A. George, J. D. Fryer, C. Krishnan, L. Buhlman, Y.-P. Kuo, O. Steinlein, and R. J. Lukas
Characterization of Human {alpha}4{beta}2-Nicotinic Acetylcholine Receptors Stably and Heterologously Expressed in Native Nicotinic Receptor-Null SH-EP1 Human Epithelial Cells
Mol. Pharmacol., December 1, 2003; 64(6): 1283 - 1294.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
C. L. Gentry, L. H. Wilkins Jr., and R. J. Lukas
Effects of Prolonged Nicotinic Ligand Exposure on Function of Heterologously Expressed, Human alpha 4beta 2- and alpha 4beta 4-Nicotinic Acetylcholine Receptors
J. Pharmacol. Exp. Ther., January 1, 2003; 304(1): 206 - 216.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
P. C. Harkness and N. S. Millar
Changes in Conformation and Subcellular Distribution of alpha 4beta 2 Nicotinic Acetylcholine Receptors Revealed by Chronic Nicotine Treatment and Expression of Subunit Chimeras
J. Neurosci., December 1, 2002; 22(23): 10172 - 10181.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
L. Lin, E. M. Jeanclos, M. Treuil, K.-H. Braunewell, E. D. Gundelfinger, and R. Anand
The Calcium Sensor Protein Visinin-like Protein-1 Modulates the Surface Expression and Agonist Sensitivity of the alpha 4beta 2 Nicotinic Acetylcholine Receptor
J. Biol. Chem., October 25, 2002; 277(44): 41872 - 41878.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
M. Katsura, Y. Mohri, K. Shuto, Y. Hai-Du, T. Amano, A. Tsujimura, M. Sasa, and S. Ohkuma
Up-regulation of L-type Voltage-dependent Calcium Channels after Long Term Exposure to Nicotine in Cerebral Cortical Neurons
J. Biol. Chem., March 1, 2002; 277(10): 7979 - 7988.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
C. Hilmas, E. F. R. Pereira, M. Alkondon, A. Rassoulpour, R. Schwarcz, and E. X. Albuquerque
The Brain Metabolite Kynurenic Acid Inhibits {alpha}7 Nicotinic Receptor Activity and Increases Non-{alpha}7 Nicotinic Receptor Expression: Physiopathological Implications
J. Neurosci., October 1, 2001; 21(19): 7463 - 7473.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
B. Buisson and D. Bertrand
Chronic Exposure to Nicotine Upregulates the Human {alpha}4{beta}2 Nicotinic Acetylcholine Receptor Function
J. Neurosci., March 15, 2001; 21(6): 1819 - 1829.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
C. P. Fenster, T. L. Whitworth, E. B. Sheffield, M. W. Quick, and R. A. J. Lester
Upregulation of Surface alpha 4beta 2 Nicotinic Receptors Is Initiated by Receptor Desensitization after Chronic Exposure to Nicotine
J. Neurosci., June 15, 1999; 19(12): 4804 - 4814.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
C. P. Fenster, M. L. Beckman, J. C. Parker, E. B. Sheffield, T. L. Whitworth, M. W. Quick, and R. A. J. Lester
Regulation of alpha 4beta 2 Nicotinic Receptor Desensitization by Calcium and Protein Kinase C
Mol. Pharmacol., March 1, 1999; 55(3): 432 - 443.
[Abstract] [Full Text]


Home page
J. Biol. Chem.Home page
F. Wang, M. E. Nelson, A. Kuryatov, F. Olale, J. Cooper, K. Keyser, and J. Lindstrom
Chronic Nicotine Treatment Up-regulates Human alpha 3beta 2 but Not alpha 3beta 4 Acetylcholine Receptors Stably Transfected in Human Embryonic Kidney Cells
J. Biol. Chem., October 30, 1998; 273(44): 28721 - 28732.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
P. Whiteaker, C. G. V. Sharples, and S. Wonnacott
Agonist-Induced Up-Regulation of alpha 4beta 2 Nicotinic Acetylcholine Receptors in M10 Cells: Pharmacological and Spatial Definition
Mol. Pharmacol., May 1, 1998; 53(5): 950 - 962.
[Abstract] [Full Text]


Home page
J. Biol. Chem.Home page
E. M. Jeanclos, L. Lin, M. W. Treuil, J. Rao, M. A. DeCoster, and R. Anand
The Chaperone Protein 14-3-3eta Interacts with the Nicotinic Acetylcholine Receptor alpha 4 Subunit. EVIDENCE FOR A DYNAMIC ROLE IN SUBUNIT STABILIZATION
J. Biol. Chem., July 20, 2001; 276(30): 28281 - 28290.
[Abstract] [Full Text] [PDF]




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 1997 by the American Society for Pharmacology and Experimental Therapeutics